XML 98 R91.htm IDEA: XBRL DOCUMENT v3.25.2
Share-based payments - Schedule of Changes in Share Options (Details)
6 Months Ended
Jun. 30, 2025
shares
May 23, 2024
shares
benefeciary
€ / shares
Jul. 20, 2023
shares
benefeciary
€ / shares
Jun. 22, 2022
shares
benefeciary
€ / shares
Jun. 21, 2021
shares
€ / shares
Apr. 20, 2021
shares
benefeciary
€ / shares
Mar. 11, 2020
shares
benefeciary
€ / shares
Oct. 24, 2019
shares
€ / shares
Mar. 29, 2019
shares
benefeciary
€ / shares
Mar. 06, 2018
shares
benefeciary
€ / shares
Jan. 07, 2017
shares
benefeciary
€ / shares
Nov. 03, 2016
shares
benefeciary
€ / shares
Feb. 02, 2016
shares
benefeciary
€ / shares
Jun. 30, 2025
shares
€ / shares
OSA 2016-1 P                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)                         450,000  
Total number of share options granted (in shares)                         6,400  
Total number of shares to which the share options were likely to give right (in shares)                         6,400  
Exercise price (in euros per share) | € / shares                         € 13.05  
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 6,000                          
Total number of share options outstanding (in shares) 400                         400
Maximum number of shares available for subscription (in shares) 400                         400
Maximum total number of shares that may be subscribed (in shares) 400                         400
OSA 2016-1 P | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary                         2  
OSA 2016-2                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)                       450,000    
Total number of share options granted (in shares)                       4,000    
Total number of shares to which the share options were likely to give right (in shares)                       4,000    
Exercise price (in euros per share) | € / shares                       € 14.26    
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 0                          
Total number of share options outstanding (in shares) 4,000                         4,000
Maximum number of shares available for subscription (in shares) 4,000                         4,000
Maximum total number of shares that may be subscribed (in shares) 4,000                         4,000
OSA 2016-2 | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary                       1    
OSA 2017 O                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)                     450,000      
Total number of share options granted (in shares)                     3,500      
Total number of shares to which the share options were likely to give right (in shares)                     3,500      
Exercise price (in euros per share) | € / shares                     € 14.97      
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 3,000                          
Total number of share options outstanding (in shares) 500                         500
Maximum number of shares available for subscription (in shares) 500                         500
Maximum total number of shares that may be subscribed (in shares) 500                         500
OSA 2017 O | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary                     2      
OSA 2018                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)                   526,800        
Total number of share options granted (in shares)                   62,000        
Total number of shares to which the share options were likely to give right (in shares)                   62,000        
Exercise price (in euros per share) | € / shares                   € 12.87        
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 12,000                          
Total number of share options outstanding (in shares) 50,000                         50,000
Maximum number of shares available for subscription (in shares) 50,000                         50,000
Maximum total number of shares that may be subscribed (in shares) 50,000                         50,000
OSA 2018 | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary                   5        
OSA 2019-1                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)                 648,000          
Total number of share options granted (in shares)                 37,500          
Total number of shares to which the share options were likely to give right (in shares)                 37,500          
Exercise price (in euros per share) | € / shares                 € 11.08          
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 12,750                          
Total number of share options outstanding (in shares) 24,750                         24,750
Maximum number of shares available for subscription (in shares) 24,750                         24,750
Maximum total number of shares that may be subscribed (in shares) 24,750                         24,750
OSA 2019-1 | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary                 12          
OSA 2019 LLY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)               500,000            
Total number of share options granted (in shares)               500,000            
Total number of shares to which the share options were likely to give right (in shares)               500,000            
Exercise price (in euros per share) | € / shares               € 6.41            
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 0                          
Total number of share options outstanding (in shares) 500,000                         500,000
Maximum number of shares available for subscription (in shares) 0                         0
Maximum total number of shares that may be subscribed (in shares) 500,000                         500,000
OSA 2019 LLY | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)               500,000            
OSA 2019 LLY | Corporate officers | Laurent LEVY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)               500,000            
OSA 2020                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)             500,000              
Total number of share options granted (in shares)             407,972              
Total number of shares to which the share options were likely to give right (in shares)             407,972              
Exercise price (in euros per share) | € / shares             € 6.25              
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 47,265                          
Total number of share options outstanding (in shares) 360,707                         360,707
Maximum number of shares available for subscription (in shares) 360,707                         360,707
Maximum total number of shares that may be subscribed (in shares) 360,707                         360,707
OSA 2020 | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)             180,000              
OSA 2020 | Corporate officers | Laurent LEVY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)             120,000              
OSA 2020 | Corporate officers | Anne-Juliette HERMANT                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)             60,000              
OSA 2020 | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary             104              
OSA 2021-04 O                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)           850,000                
Total number of share options granted (in shares)           143,200                
Total number of shares to which the share options were likely to give right (in shares)           143,200                
Exercise price (in euros per share) | € / shares           € 13.74                
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 104,668                          
Total number of share options outstanding (in shares) 38,532                         38,532
Maximum number of shares available for subscription (in shares) 38,532                         38,532
Maximum total number of shares that may be subscribed (in shares) 38,532                         38,532
OSA 2021-04 O | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary           13                
OSA 2021-04 P                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)           1,000,000                
Total number of share options granted (in shares)           428,000                
Total number of shares to which the share options were likely to give right (in shares)           428,000                
Exercise price (in euros per share) | € / shares           € 13.74                
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 87,400                          
Total number of share options outstanding (in shares) 340,600                         340,600
Maximum total number of shares that may be subscribed (in shares) 340,600                         340,600
OSA 2021-04 P | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)           240,000                
OSA 2021-04 P | Corporate officers | Laurent LEVY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)           180,000                
OSA 2021-04 P | Corporate officers | Anne-Juliette HERMANT                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)           60,000                
OSA 2021-04 P | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary           14                
OSA 2021-06 P                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)         1,000,000                  
Total number of share options granted (in shares)         60,000                  
Total number of shares to which the share options were likely to give right (in shares)         60,000                  
Exercise price (in euros per share) | € / shares         € 12.99                  
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 0                          
Total number of share options outstanding (in shares) 60,000                         60,000
Maximum total number of shares that may be subscribed (in shares) 60,000                         60,000
OSA 2021-06 P | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)         60,000                  
OSA 2021-06 P | Corporate officers | Bart VAN RHIJN                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)         60,000                  
OSA 2021-06 O                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)         850,000                  
Total number of share options granted (in shares)         60,000                  
Total number of shares to which the share options were likely to give right (in shares)         60,000                  
Exercise price (in euros per share) | € / shares         € 12.99                  
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 0                          
Total number of share options outstanding (in shares) 60,000                         60,000
Maximum number of shares available for subscription (in shares) 60,000                         60,000
Maximum total number of shares that may be subscribed (in shares) 60,000                         60,000
OSA 2021-06 O | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)         60,000                  
OSA 2021-06 O | Corporate officers | Bart VAN RHIJN                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)         60,000                  
OSA 2022-06 P                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)       1,000,000                    
Total number of share options granted (in shares)       170,400                    
Total number of shares to which the share options were likely to give right (in shares)       170,400                    
Exercise price (in euros per share) | € / shares       € 4.16                    
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 46,620                          
Total number of share options outstanding (in shares) 123,780                         123,780
Maximum total number of shares that may be subscribed (in shares) 123,780                         123,780
OSA 2022-06 P | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary       83                    
OSA 2022-06 O                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)       850,000                    
Total number of share options granted (in shares)       410,500                    
Total number of shares to which the share options were likely to give right (in shares)       410,500                    
Exercise price (in euros per share) | € / shares       € 4.16                    
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 30,500                          
Total number of share options outstanding (in shares) 380,000                         380,000
Maximum number of shares available for subscription (in shares) 380,000                         380,000
Maximum total number of shares that may be subscribed (in shares) 380,000                         380,000
OSA 2022-06 O | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)       245,000                    
OSA 2022-06 O | Corporate officers | Laurent LEVY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)       150,000                    
OSA 2022-06 O | Corporate officers | Anne-Juliette HERMANT                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)       35,000                    
OSA 2022-06 O | Corporate officers | Bart VAN RHIJN                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)       60,000                    
OSA 2022-06 O | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary       49                    
OSA 2023-01 O                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)     1,700,000                      
Total number of share options granted (in shares)     338,860                      
Total number of shares to which the share options were likely to give right (in shares)     338,860                      
Exercise price (in euros per share) | € / shares     € 5.00   € 5.00                  
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 20,000                          
Total number of share options outstanding (in shares) 318,860                         318,860
Maximum number of shares available for subscription (in shares) 106,288                         106,288
Maximum total number of shares that may be subscribed (in shares) 318,860                         318,860
OSA 2023-01 O | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)     298,860                      
OSA 2023-01 O | Corporate officers | Laurent LEVY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)     200,116                      
OSA 2023-01 O | Corporate officers | Anne-Juliette HERMANT                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)     33,354                      
OSA 2023-01 O | Corporate officers | Bart VAN RHIJN                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)     65,390                      
OSA 2023-01 O | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary     2                      
OSA 2024-01 O                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)   1,700,000                        
Total number of share options granted (in shares)   1,224,780                        
Total number of shares to which the share options were likely to give right (in shares)   1,224,780                        
Exercise price (in euros per share) | € / shares   € 5.81     € 5.81                  
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 5,250                          
Total number of share options outstanding (in shares) 1,219,530                         1,219,530
Maximum number of shares available for subscription (in shares) 406,510                         406,510
Maximum total number of shares that may be subscribed (in shares) 1,219,530                         1,219,530
OSA 2024-01 O | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   930,000                        
OSA 2024-01 O | Corporate officers | Laurent LEVY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   500,000                        
OSA 2024-01 O | Corporate officers | Anne-Juliette HERMANT                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   90,000                        
OSA 2024-01 O | Corporate officers | Bart VAN RHIJN                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   180,000                        
OSA 2024-01 O | Corporate officers | Louis Kayitalire                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   160,000                        
OSA 2024-01 O | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary   107                        
OSA 2025-01 O                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)     1,700,000                      
Total number of share options granted (in shares)     8,000                      
Total number of shares to which the share options were likely to give right (in shares)     8,000                      
Exercise price (in euros per share) | € / shares     € 3.36                     € 3.36
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 0                          
Total number of share options outstanding (in shares) 8,000                         8,000
Maximum number of shares available for subscription (in shares) 0                         0
Maximum total number of shares that may be subscribed (in shares) 8,000                         8,000
OSA 2025-01 O | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)     0                      
OSA 2025-01 O | Corporate officers | Laurent LEVY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)     0                      
OSA 2025-01 O | Corporate officers | Anne-Juliette HERMANT                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)     0                      
OSA 2025-01 O | Corporate officers | Bart VAN RHIJN                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)     0                      
OSA 2025-01 O | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary     2                      
OSA 2025-02 O                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of share options authorised (in shares)   1,700,000                        
Total number of share options granted (in shares)   1,241,005                        
Total number of shares to which the share options were likely to give right (in shares)   1,241,005                        
Exercise price (in euros per share) | € / shares   € 2.97                       € 2.97
Number of shares subscribed (in shares) 0                          
Total number of share options lapsed or cancelled (in shares) 1                          
Total number of share options outstanding (in shares) 1,241,004                         1,241,004
Maximum number of shares available for subscription (in shares) 0                         0
Maximum total number of shares that may be subscribed (in shares) 1,241,004                         1,241,004
OSA 2025-02 O | Corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   945,000                        
OSA 2025-02 O | Corporate officers | Laurent LEVY                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   505,000                        
OSA 2025-02 O | Corporate officers | Anne-Juliette HERMANT                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   100,000                        
OSA 2025-02 O | Corporate officers | Bart VAN RHIJN                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   190,000                        
OSA 2025-02 O | Corporate officers | Louis Kayitalire                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Total number of shares to which the share options were likely to give right (in shares)   150,000                        
OSA 2025-02 O | Beneficiaries other than corporate officers                            
Disclosure Of Detailed Information About Share-based Payments [Line Items]                            
Number of beneficiaries who are not corporate officers | benefeciary   105